Clinical and genetic risk factors of herpes zoster in patients with systemic lupus erythematosus

Rheumatology International

Volumn 25, Issue 2, 2005, Pages 97-102

  Kang, Tae Young ^a   Lee, Hye Soon ^a   Kim, Tae Hwan ^a   Jun, Jae Bum ^a   Yoo, Dae Hyun ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

Fc R polymorphism; Herpes zoster; Human leukocyte antigen DRB1; Systemic lupus erythematosus

Indexed keywords

DNA; FC RECEPTOR; HLA DR ANTIGEN; RECEPTOR SUBTYPE; SM ANTIBODY;

ADULT; ALLELE; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC RISK; GENOTYPE; HERPES ZOSTER; HUMAN; INFECTION RATE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT INFORMATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AUTOANTIGENS; FEMALE; HERPES ZOSTER; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; RETROSPECTIVE STUDIES; RIBONUCLEOPROTEINS, SMALL NUCLEAR; RISK FACTORS;

EID: 16344371431     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-003-0403-3     Document Type: Article

References (32)

1. Choo PW, Donahue JG, Manson JE, Platt R (1995) The epidemiology of Varicella and its complications. J Infect Dis 172:706-712
2. Nagasawa K, Yamauchi Y, Tada Y, Kusaba T, Niho Y, Yoshikawa H (1990) High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann Rheum Dis 49:630-633
3. Grose C, Litwin V (1988) Immunology of the Varicella-zoster virus glycoproteins. J Infect Dis 157:877-881
4. Ogata M, Shigeta S (1979) Appearance of immunoglobulin G Fc receptor in cultured human cells infected with Varicella-zosler virus. Infect Immun 26:770-774
5. Clark MR, Clarkson SB, Ory PA, Stollman N, Goldstein IM (1989) Molecular basis for a polymorphism involving Fc receptor II on human monocytes. J Immunol 143:1731-1734
6. Warmerdam PA, van de Winkel JG, Gosselin EJ, Capel PJ (1990) Molecular basis for a polymorphism of human Fc gamma receptor II (CD32). J Exp Med 172:19-25
7. Salmon JE, Edberg JC, Brogle NL, Kimberly RP (1992) Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest 89:1274-1281
8. Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ (1991) A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol 147:1338-1343
9. Sanders LA, van de Winkel JG, Rijkers GT, Voorhorst-Ogink MM, de Haas M, Capel PJ, Zegers BJ (1994) Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 170:854-861
10. Bredius RG, Derkx BH, Fijen CA, de Wit TP, de Haas M, Weening RS, van de Winkel JG, Out TA (1994) Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 170:848-853
11. Duits AJ, Bootsma H, Derksen RH, Spronk PE, Kater L, Kallenberg CG, Capel PJ, Westerdaal NA, Spierenburg GT, Gmelig-Meyling FH et al (1995) Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 38:1832-1836
12. Botto M, Theodoridis E, Thompson EM, Beynon HL, Briggs D, Isenberg DA, Walport MJ, Davies KA (1996) Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin Exp Immunol 104:264-268
13. Radeke HH, Gessner JE, Uciechowski P, Magert HJ, Schmidt RE, Resch K (1994) Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma chain. J Immunol 153:1281-1292
14. Abendroth A, Slobedman B, Lee E, Mellins E, Wallace M, Arvin AM (2000) Modulation of major histocompatibility class II protein expression by Varicella-zoster virus. J Virol 74:1900-1907
15. Donahue JG, Choo PW, Manson JE, Platt R (1995) The incidence of herpes zoster. Arch Intern Med 155:1605-1609
16. Ragozzino MW, Melton LJ III, Kurland LT, Chu CP, Perry HO (1982) Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 61:310-316
17. Vachtenheim J, Grossmann J (1965) The herpetic viral diseases and systemic lupus erythematosus. Pol Tyg Lek 20:1854-1856
18. Moutsopoulos HM, Gallagher JD, Decker JL, Steinberg AD (1978) Herpes zoster in patients with systemic lupus erythematosus. Arthritis Rheum 21:798-802
19. Manzi S, Kuller LH, Kutzer J, Pazin GJ, Sinacore J, Medsger TA Jr, Ramsey-Goldman R (1995) Herpes zoster infection in systemic lupus erythematosus. J Rheumatol 22:1254-1258
20. Burgoon CF, Brugoon JS, Baldrige GD (1957) The natural history of herpes zoster. JAMA 164:265-269
21. Weller TH (1983) Varicella and herpes zoster: changing concepts of the natural history, control, and importance of a not-so-benign virus (first of two parts). N Engl J Med 309:1362-1368
22. Kamiya H, Ihara T, Hattori A et al (1977) Diagnostic skin test reactions with Varicella virus antigen and clinical applications of the test. J Infect Dis 136:784-788
23. Bruke BL, Steele RW, Beard OW, Wood JS, Cain TD, Marmer DJ (1982) Immune responses to Varicella-zoster in the aged. Arch Intern Med 142:291-293
24. Notman DD, Kurata N, Tan EM (1975) Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med 83:464-469
25. Janwityanuchit S, Verasertniyom O, Vanichapuntu M, Vatanasuk M (1993) Anti-Sm: its predictive value in systemic lupus erythematosus. Clin Rheumatol 12: 350-353
26. Elkon KB (2000) Autoantibodies in SLE. In: Klippel JH, Dieppe PA (eds) Rheumatology. 2nd edn. Mosby, London, pp 7.5.1-7.5.10
27. Huong DLT, Papo T, Beaufils H et al (1999) Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine 72:209-220
28. Fessler BJ (2000) Assessing disease activity and outcome in systemic lupus erythematosus. In: Klippel JH, Dieppe PA (eds) Rheumatology. 2nd edn. Mosby, London, pp 7.8.5-7.8.6
29. Principato MA, Thompson GS, Friedman SM (1983) cloned major histocompatibility complex-restricted trinitrophenyl-reactive human helper T cell line that activates B cell subsets via two distinct pathways. J Exp Med 158:1444-1458
30. Goodman JW, Parslow TG (1994) Immunoglobulin proteins. In: Stites DP, Terr AI, Parslow TG (eds) Basic and clinical immunology. 8th edn. Appleton and Lange, Connecticut, pp 74-75
31. Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, Ramsey-Goldman R, Peterson MG, Kimberly RP (1996) Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 97:1348-1354
32. Manger K, Repp R, Jansen M, Geisselbrecht M, Wassmuth R, Westerdaal NA, Pfahlberg A, Manger B, Kalden JR, van de Winkel JG (2002) Fc gamma receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms. Ann Rheum Dis 61:786-792